Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats

Table 2

Serum α-amylase, total protein, albumin, and globulin concentration in diabetic rats treated with combined IP6 and inositol supplement or glibenclamide.

Parameters	NC	HFC	DC	IP6 + INO	Glib
α-Amylase activity (U/L)	1599 ± 21^bc	1544 ± 57^ab	1457 ± 31^a	1689 ± 19^c	1655 ± 38^bc
Total protein (g/dL)	7.9 ± 0.16^a	8.4 ± 0.19^a	7.8 ± 0.23^a	7.9 ± 0.26^a	8 ± 0.26^a
Albumin (g/dL)	5.13 ± 0.14^a	4.81 ± 0.16^a	4.38 ± 0.09^b	4.5 ± 0.17^b	4.45 ± 0.12^b
Globulin (g/dL)	3.1 ± 0.41^a	3.5 ± 0.31^a	3.38 ± 0.29^a	3.28 ± 0.24^a	3.58 ± 0.26^a

Note. Data are shown as mean ± S.E.M (n = 6). The mean values in a row with different superscript letters are significantly different at , as assessed by Duncan’s multiple range test. NC, normal control; HFC, high-fat control; DC, diabetic untreated control; IP6 + INO, combined IP6 and inositol.